医院模板
  • HOME
  • | /
  • ABOUT
    • Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
    • Collaborators
  • | /
  • R&D
    • TNP-2092 IV
    • TNP-2092 PO
    • TNP-2198 PO
    • TNP-2092 Topical
    • CRAB
    • NTM
  • | /
  • NEWS
    • Company News
    • Publications
    • Industry News
  • | /
  • JOIN US
    • Activities
    • Job Openings
  • | /
  • CONTACT
  • 中文
  • EN

TenNor Was Named as One of the Potential Unicorn Enterprises in Suzhou

2020-06-19 13:30

huojiang.jpg

   

TenNor was named as One of the Potential Unicorn Enterprises in Suzhou.

Please click here for details:https://www.sohu.com/na/402672110_349645



share
WeChat
Sina Weibo
Facebook
Twitter
LinkedIn
Company News
Prev TenNor and Mayo Clinic Researchers Publish Article on Biofilm Bactericidal Activity of TNP-2092
Next TenNor Publishes Article on Synergistic Activity of Oxazolidinone-Nitroimidazole Conjugates

ABOUT

Overview

Team

Board of Directors

Scientific Advisory Board

Investors

Collaborators

R&D

TNP-2092 IV

TNP-2092 PO

TNP-2198 PO

TNP-2092 Topical

CRAB

NTM


NEWS

Company News

Publications

Industry News

JOIN US

Activities

Job Openings

 

CONTACT


©2013 TENNOR THERAPEUTICS LTD

电话咨询:020-000000
QQ咨询:258506508
微信客服
扫码咨询